57894-0510
RYBREVANT FASPRO
AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
INJECTION
Subcutaneous
AMIVANTAMAB
1600.0
mg/10mL
HYALURONIDASE (HUMAN RECOMBINANT)
20000.0
mg/10mL
57894-0510-01
1 VIAL, SINGLE-DOSE in 1 CARTON (57894-510-01) / 10 mL in 1 VIAL, SINGLE-DOSE
Dec. 17, 2025
Immunotherapy
Bispecific Antibody
EGFR, MET
In Use
Home